Indefinite Delivery Contract SPE2DU25D3516

The federal contract IDV award with ID SPE2DU25D3516 is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across various therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention.

The original solicitation, which is expected to be issued in March 2024, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and US Naval Fleet. The procurement will be a Lowest Price Technically Acceptable acquisition, with the intent to make multiple awards for separate regions, including North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet. Both primary and backup suppliers will be selected, with each providing separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally.